Original Article

You have full text access to this OnlineOpen article

Cytomegalovirus pneumonia in patients with lymphoma†

  1. Roy F. Chemaly M.D., M.P.H.1,§,*,
  2. Harrys A. Torres M.D.1,
  3. Ray Y. Hachem M.D.1,
  4. Graciela M. Nogueras M.P.H.2,‡,
  5. Elizabeth A. Aguilera M.D.1,
  6. Anas Younes M.D.3,
  7. Mario A. Luna M.D.4,
  8. Gilhen Rodriguez M.D.1,
  9. Jeffrey J. Tarrand M.D.5,
  10. Issam I. Raad M.D.1

Article first published online: 2 AUG 2005

DOI: 10.1002/cncr.21294

Issue

Cancer

Cancer

Volume 104, Issue 6, pages 1213–1220, 15 September 2005

Additional Information

How to Cite

Chemaly, R. F., Torres, H. A., Hachem, R. Y., Nogueras, G. M., Aguilera, E. A., Younes, A., Luna, M. A., Rodriguez, G., Tarrand, J. J. and Raad, I. I. (2005), Cytomegalovirus pneumonia in patients with lymphoma. Cancer, 104: 1213–1220. doi: 10.1002/cncr.21294

Author Information

  1. 1

    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  2. 2

    Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  3. 3

    Department of Lymphoma, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  4. 4

    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  5. 5

    Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  1. ‡

    Department of Biostatistics, U54 Puerto Rico Cancer Centre, San Juan, Puerto Rico

  1. §

    Fax: (713) 745-6839

*Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M. D. Anderson Cancer Center, P. O. Box 301402, Houston, TX 77230-1402

  1. †

    Presented, in part, at the 13th International Symposium on Infections in the Immunocompromised, Granada, Spain, June 27–30, 2004.

Publication History

  1. Issue published online: 31 AUG 2005
  2. Article first published online: 2 AUG 2005
  3. Manuscript Accepted: 25 APR 2005
  4. Manuscript Revised: 15 APR 2005
  5. Manuscript Received: 6 JAN 2005

Funded by

  • The University of Texas M. D. Anderson Cancer Center
  • Puerto Rico Cancer Center. Grant Number: U54 CA96297

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (129K)

REFERENCES

  • 1
    Konoplev S, Champlin RE, Giralt S, et al. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant. 2001; 27: 877–881.
  • 2
    Nguyen Q, Estey E, Raad I, et al. Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis. 2001; 32: 539–545.
  • 3
    Salomon N, Perlman DC. Cytomegalovirus pneumonia. Semin Respir Infect. 1999; 14: 353–358.
  • 4
    Kruger RM, Paranjothi S, Storch GA, Lynch JP, Trulock EP. Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients. J Heart Lung Transplant. 2003; 22: 754–763.
  • 5
    Manna A, Cordani S, Canessa P, Pronzato P. CMV infection and pneumonia in hematological malignancies. J Infect Chemother. 2003; 9: 265–267.
  • 6
    Mera JR, Whimbey E, Elting L, et al. Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: review of 20 cases occurring from 1964 through 1990. Clin Infect Dis. 1996; 22: 1046–1050.
  • 7
    Rosen P, Hajdu S. Cytomegalovirus inclusion disease at autopsy of patients with cancer. Am J Clin Pathol. 1971; 55: 749–756.
  • 8
    Casazza AR, Duvall CP, Carbone PP. Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA. 1966; 197: 710–716.
  • 9
    Lundin J, Hagberg H, Repp R, et al. Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome. Blood. 2003; 101: 4267–4272.
  • 10
    Nguyen DD, Cao TM, Dugan K, Starcher SA, Fechter RL, Coutre SE. Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia. Clin Lymphoma. 2002; 3: 105–110.
  • 11
    Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002; 34: 1094–1097.
  • 12
    Daniel WW. The chi-square distribution and the analysis of frequencies. In: DanielWW, editor. Biostatistics: a foundation for analysis in the health sciences. 7th ed. New York: John Wiley & Sons, 1999: 606–607.
  • 13
    Duvall CP, Casazza AR, Grimley PM, Carbone PP, Rowe WP. Recovery of cytomegalovirus from adults with neoplastic disease. Ann Intern Med. 1966; 64: 531–541.
  • 14
    Bowden RA. Antivirals for CMV. Amsterdam: Elsevier, 1993.
  • 15
    Gleaves CA, Smith TF, Shuster EA, Pearson GR. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol. 1985; 21: 217–221.
  • 16
    Ljungman P. Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Semin Respir Infect. 1995; 10: 209–215.
  • 17
    Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005; 84: 1–12.
  • 18
    de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol. 2002; 25(Suppl. 2): S1–12.
  • 19
    Riddell SR. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Semin Respir Infect. 1995; 10: 199–208.
  • 20
    Slivnick DJ, Ellis TM, Nawrocki JF, Fisher RI. The impact of Hodgkin's disease on the immune system. Semin Oncol. 1990; 17: 673–682.
  • 21
    Wood GS, Edinger A, Hoppe RT, Warnke RA. Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype. J Cutan Pathol. 1994; 21(2): 151–156.
    Direct Link:
  • 22
    Myerson D, Hackman RC, Meyers JD. Diagnosis of cytomegaloviral pneumonia by in situ hybridization. J Infect Dis. 1984; 150: 272–277.
  • 23
    Tamm M, Traenkle P, Grilli B, et al. Pulmonary cytomegalovirus infection in immunocompromised patients. Chest. 2001; 119: 838–843.
  • 24
    Emanuel D, Peppard J, Stover D, Gold J, Armstrong D, Hammerling U. Rapid immunodiagnosis of cytomegalovirus pneumonia by bronchoalveolar lavage using human and murine monoclonal antibodies. Ann Intern Med. 1986; 104: 476–481.
  • 25
    Crawford SW, Bowden RA, Hackman RC, Gleaves CA, Meyers JD, Clark JG. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture. Ann Intern Med. 1988; 108: 180–185.
  • 26
    Goldstein LC, McDougall J, Hackman R, Meyers JD, Thomas ED, Nowinski RC. Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun. 1982; 38: 273–281.
  • 27
    Chemaly RF, Yen-Lieberman B, Castilla EA, et al. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol. 2004; 42: 2168–2172.
  • 28
    Meyers JD, Ljungman P, Fisher LD. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis. 1990; 162: 373–380.
  • 29
    Rook AH. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis. 1988; 10(Suppl. 3): S460–467.
  • 30
    Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002; 100: 4358–4366.
  • 31
    Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis. 1998; 26: 753–755.
  • 32
    Crumpacker C, Marlowe S, Zhang JL, Abrams S, Watkins P. Treatment of cytomegalovirus pneumonia. Rev Infect Dis. 1988; 10(Suppl. 3): S538–546.
View Full Article (HTML) Get PDF (129K)